![Medtronic plc Website](https://cdn.finchat.io/31348.png)
Medtronic plc
NYSE-MDT
Company Overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Name
Medtronic plc
CEO
Mr. Geoffrey Straub Martha
Website
www.medtronic.com
Sector
Health Care Equipment and Supplies
Year Founded
1949
Profile
Market Cap
$115.28B
EV
$135.47B
Shares Out
1,282.49M
Revenue
$32.58B
Employees
95,000
Margins
Gross
65.52%
EBITDA
27.67%
Operating
19.57%
Pre-Tax
15.07%
Net
12.05%
FCF
15.79%
Returns (5Yr Avg)
ROA
4.62%
ROTA
12.46%
ROE
8.26%
ROCE
7.31%
ROIC
7.17%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$94.62
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$7,843M
Net Debt
$19.98B
Debt/Equity
0.58
EBIT/Interest
8.64
Growth (CAGR)
Rev 3Yr
1.02%
Rev 5Yr
1.22%
Rev 10Yr
6.67%
Dil EPS 3Yr
1.27%
Dil EPS 5Yr
-1.86%
Dil EPS 10Yr
0.03%
Rev Fwd 2Yr
4.24%
EBITDA Fwd 2Yr
6.08%
EPS Fwd 2Yr
6.01%
EPS LT Growth Est
5.55%
Dividends
Yield
—
Payout
93%
DPS
$2.77
DPS Growth 3Yr
5.34%
DPS Growth 5Yr
6.31%
DPS Growth 10Yr
9.24%
DPS Growth Fwd 2Yr
1.98%